In this study, a sensitive, specific assay for the determination of TNP-470 and its two major metabolites M-IV (also know as AGM-1883) and M-II in human plasma is reported. The assay involves liquid-liquid extraction of acidified plasma followed by reversedphase high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry. A liquid-liquid extraction using an organic solvent mixture (methyltert-butyl-ether-hexane, 1:1, v/v) is used in place of solid-phase extraction because it provides consistent recoveries for all analytes, including the internal standard. Retention times for the analytes and internal standard are less than 7 min. Within-and between-day precision is ≤ ≤ 6.5% and ≤ ≤ 13.3% relative standard deviation, respectively, for the three analytes. The lower limits of quantitation are 0.25, 0.5, and 1.0 ng/mL for TNP-470, M-IV, and M-II, respectively.
Introduction
O-(Chloroacetylcarbamoyl) fumagillol, or AGM-1470 (later termed TNP-470), is a semisynthetic analog of fumagillin, which is an angiostatic antibiotic derived from Aspergillus fumigatus fresenius. This agent is a potent inhibitor of endothelial cell proliferation in vitro, being 50 times more potent than fumagillin (IC 50 ≅ 10 pg/mL). It inhibits angiogenesis in vivo in a variety of assays, including the chorioallantoic membrane, rat corneal micropocket, and murine sponge implantation assays (1) .
TNP-470 has demonstrated activity against a wide variety of rodent and human tumor types, inhibiting tumorigenesis and growth of de novo tumors by inhibiting neovascularization. Direct cytotoxicity is not felt to play a role in the antitumor activity of this agent. Clinical trials are currently evaluating the role of this agent as monotherapy and as a component of combination 
Preparation of standard and quality control samples
Reference solutions of TNP-470, M-IV, and M-II were prepared as 1.0-mg/mL solutions in water-acetonitrile (1:1, v/v) with 0.1% phosphoric acid and stored at -10°C to -30°C. Two reference solutions of each analyte were prepared from independent weighings; the first solution was used to prepare calibration standards in human plasma and the second was for quality control (QC) samples (also in human plasma). These reference solutions were further diluted in the same solvent to obtain a single working reference solution containing a mixture of each analyte at a concentration of 10,000 ng/mL. This working reference solution was stored at -60°C to -80°C and thawed at room temperature before use.
Preparation of standards
Pooled control human plasma was first acidified with 0.2 mL of a 250-mg/mL citric acid solution per 10 mL of whole blood or equivalent. Working calibration solutions containing 2.5, 5, 10, 25, 50, 100, 250, 500, and 1000 ng/mL of each analyte were prepared by diluting the working reference solution with water-acetonitrile (1:1, v/v) with 1% acetic acid. A 0.1-mL aliquot of each of these calibration solutions was added to 1 mL citrated human plasma to obtain nine plasma standards ranging in concentration from 0.25 to 100 ng/mL of each analyte.
Preparation of QC samples
QC samples were prepared in a manner similar to the calibration standards. Two stock spiking solutions in plasma (1000 and 10,000 ng/mL) containing each analyte were prepared by spiking acidified plasma with the reference solutions (1 mg/mL) described previously. These stock spiking solutions in plasma were then diluted with acidified plasma to obtain QC samples at four concentration levels corresponding with 1.5, 15, 75, and 200 ng/mL (designated as low-level, intermediatelevel, high-level, and over-curve-level QC, respectively). Over-curve QC samples were analyzed using a 5X dilution of the aliquot volume diluted to full volume with blank plasma. The accuracy, defined as a percentage of the theoretical concentration (mean concentration / theoretical concentration × 100), and precision (percent relative standard deviation, RSD) of the method are presented in Table I . layer. The upper organic layer was transferred into a clean tube and evaporated under nitrogen to dryness using a Turbo-Vap apparatus (Zymark, Hopkinton, MA) set at 40°C. The residue was reconstituted with 100 µL of water-acetonitrile (1:1, v/v) with 0.1% acetic acid. Typically, 25 µL was injected into the HPLC-MS-MS system.
Sample preparation

Apparatus
Mobile phase was delivered by a Hewlett-Packard (Wilmington, DE) 1090 L system at a flow rate of 0.40 mL/min. Analytes were separated using a reversed-phase analytical column (ODS-AQ, 5 µm, 150 × 4.6 mm) (YMC, Wilmington, NC) at a column temperature of 50°C.
A Sciex API III triple quadrupole MS (PE-Sciex, Thornhill, Canada) was used for analyte detection. Analytes from the HPLC column were ionized by atmospheric pressure chemical ionization via a heated nebulizer interface at 475°C. Nitrogen was used as the nebulizer gas at a pressure of 80 psi, and the nitrogen auxiliary gas flow was 3600 mL/min. The curtain gas was nitrogen, and it was held at a flow rate of 1800 mL/min. Mass analysis and quantitation of the analytes were performed in the positive-ion mode under selected reaction monitoring conditions. The orifice potential was maintained at 40 V, and the collision gas (10% nitrogen BAL argon) thickness was approximately 260 × 10 13 atoms/cm 3 This methodology was also cross-validated using a Sciex API 3000 triple quadrupole MS (PE-Sciex). The heated nebulizer interface was held at a temperature of 450°C. Nitrogen was used as the nebulizer gas at a flow setting of 10 psi, and the air auxiliary gas flow was held at a rate of 8000 mL/min. The curtain gas was nitrogen at a flow setting of 10. The collision gas was 10% nitrogen BAL argon at a flow setting of 4. Dwell times were 100 ms (internal standard) or 200 ms (other analytes).
Results and Discussion
The mass chromatographic conditions for this study were selected based upon previous experience as described by Ong et al. (6) . Fullscan positive-ion mass spectra for the three analytes were used to confirm the chromatographic elution order (on the C18 analytical HPLC column). Characteristic product ions were produced via collision-activated dissociation, and these data provided the selected reaction channels to be monitored for analyte quantitation.
Again, based in part upon the work of Ong et al. (6) , it was decided to use acidified whole blood to provide plasma samples for analysis. This was because of the variable, but extensive, loss of TNP-470 prior to plasma harvesting (range of loss = 17% to 99%). Citric acid proved to be an ideal acidifier because it can act as an anticoagulant at the same time. 100 ng/mL for TNP-470, M-IV, and M-II, respectively. Precision of the QC samples ranged from 1.0% to 1.5% RSD, 3.0% to 6.6% RSD, and 1.3% to 3.3% RSD for TNP-470, M-IV, and M-II, respectively. Accuracy, determined by comparing the measured with theoretical concentrations of calibration standards, ranged from -7.6% to 15%, -15.0% to 12.0%, and -4.7% to 4.6% for TNP-470, M-IV, and M-II, respectively. Accuracy, determined as percentage deviation from theoretical concentrations for QC standards, ranged from -10.6% to -5.2%, 2.0% to 4.1%, and -10.2% to -4.0% for TNP-470, M-IV, and M-II, respectively. Thus, use of the Sciex API 3000 MS demonstrated acceptable precision and accuracy as compared with results with the API III apparatus.
